The enhanced Affordable Care Act subsidies that were at the center of the October government shutdown were not only made available to people making as much as $500,000 annually but also turned out to be rife with waste, fraud, and abuse. A December 3, 2025, Government Accountability Office (GAO) report revealed that the advanced premium […]
As Americans gather with family and friends to celebrate Thanksgiving, healthcare costs are one of their main concerns. President Trump has made lowering drug prices and increasing domestic biopharmaceutical research and development high priorities in his second term in office. Domestic investment by drug companies has skyrocketed since Eli Lilly was the first company to […]
The United States is the global leader in developing innovative and life-saving cures and treatments thanks to the investments made by pharmaceutical companies in the United States, including the vaccines that helped end the coronavirus pandemic. Vaccines are crucial to the physical and economic health of not just Americans but also people across the rest […]
The 340B Drug Discount Program was given the laudable goal of helping federally funded clinics and public hospitals that serve a large uninsured population cover the cost of drugs and provide discounts to patients. However, like many other well-intended federal programs 340B has gone off the rails due to the lack of clear intent and […]
President Trump has made lowering drug prices and reducing healthcare costs for Americans a top priority of his second term, along with encouraging more biopharmaceutical investment and innovation in the U.S. Citizens Against Government Waste suggests that he can achieve both objectives without imposing price controls, which includes Most Favored Nation (MFN) polices, reforming the […]
The Congressional Budget Office (CBO) has confirmed what the Council for Citizens Against Government Waste (CCAGW) has long been saying about the 340B drug discount program. The September 9, 2025, CBO report noted that 340B has grown substantially and increases costs for taxpayers. The CBO report also underscores several reasons why reforms to the 340B […]
The 340B Drug Discount Program was created in 1992 to help federally funded clinics and public hospitals that serve a large uninsured population cover the cost of drugs and provide discounts to patients. But the lack of guardrails on the program and failure to define a patient has led to it being abused by hospitals […]
Eliminating waste, fraud, abuse, and inefficiency in government and restoring common sense has been a priority for President Trump and Congress for 2025. As part of this effort, lawmakers should turn their attention to eliminating an unnecessary, wasteful, and outdated rule that would modernize how critical medical information is disseminated. Modernizing this rule would restore […]
As senators consider H.R 1, the One Big Beautiful Bill Act (OBBA), they have an opportunity to agree with the House to close a loophole that harms American companies and jobs. This loophole, known as a duty drawback, allows companies to avoid paying an excise tax and then claim a refund for the amount they […]
Welcome to This Week in Waste, a series by Citizens Against Government Waste (CAGW) that highlights how taxpayer dollars are being wasted in the federal, state, and local levels of government and efforts to fight back against this spendthrift behavior. Congress to Vote on Codifying DOGE Cuts Congress is expected to take up a recissions […]
